Nuvo Pharmaceuticals Inc NRIFF

Primary Symbol: MRVFF

Healthcare Drug Manufacturers - Specialty & Generic

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.

OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc

Bullboard Posts

Post by need2stockupon Mar 08, 2013 3:37pm

209 Views

Post# 21102169

Nobody can see what's going on

NRI was affected by Voltaren when they received FDA approval first for their gel and Pennsaid was delayed. NRI was delayed and Voltaren got more established. Now NRI is trying to put gel on the market and this is really causing eyes to roll. I say the delay was predicable and again Voltaren will get more established. Delaying a new market product can put millions in Voltarens pockets. Pennsaid might be the best product for the job, but Voltaren has established their customer base faster and better then Covidien. Can manufactures have influence with the FDA? Past history says yes. Is that what is going on now? Who knows. Guess what NRI is going down further. Mark my words. Put your buys in at .03. The all time low. Need2.